Newsroom
Newsroom
Industry News
- August 12, 2021
California synthetic biology firm Antheia has joined forces with Boston-based biotech company Ginkgo Bioworks to strengthen its efforts to develop and produce essential medicines to...
Press Releases
- August 12, 2021
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a...
Industry News
- August 11, 2021
With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy,...
Industry News
- July 28, 2021
Fundraising at Bota Bio, Genomatica, and Antheia signals an upshift for commercial-scale synthetic biology......
Industry News
- July 8, 2021
Antheia, a Menlo Park CA-based synthetic biology company, raised $73M in Series B funding. The round was led by Viking Global Investors with participation from...
Industry News
- July 8, 2021
Antheia, a synthetic biology company working to develop plant-inspired medicine, has officially secured a fresh $73 million in Series B funding......
Industry News
- August 12, 2021
California synthetic biology firm Antheia has joined forces with Boston-based biotech company Ginkgo Bioworks to strengthen its efforts to develop and produce essential medicines to...
Press Releases
- August 12, 2021
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a...
Industry News
- August 11, 2021
With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy,...
Industry News
- July 28, 2021
Fundraising at Bota Bio, Genomatica, and Antheia signals an upshift for commercial-scale synthetic biology......
Industry News
- July 8, 2021
Antheia, a Menlo Park CA-based synthetic biology company, raised $73M in Series B funding. The round was led by Viking Global Investors with participation from...
Industry News
- July 8, 2021
Antheia, a synthetic biology company working to develop plant-inspired medicine, has officially secured a fresh $73 million in Series B funding......
Industry News
- April 1, 2017
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
- January 15, 2017
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
- May 31, 2016
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...
Industry News
- December 17, 2015
Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of...
Industry News
- August 13, 2015
Over the past several months, scientists from around the world have published bits and pieces of a fascinating feat: In an effort to create pain...